GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Tobacco Products » Altria Group Inc (NYSE:MO) » Definitions » Research & Development

Altria Group (Altria Group) Research & Development : $0 Mil (TTM As of Dec. 2023)


View and export this data going back to 1985. Start your Free Trial

What is Altria Group Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Altria Group's Research & Development for the three months ended in Dec. 2023 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $0 Mil.


Altria Group Research & Development Historical Data

The historical data trend for Altria Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Altria Group Research & Development Chart

Altria Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Altria Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Altria Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Altria Group  (NYSE:MO) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Altria Group Research & Development Related Terms

Thank you for viewing the detailed overview of Altria Group's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Altria Group (Altria Group) Business Description

Address
6601 West Broad Street, Richmond, VA, USA, 23230
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Horizon Innovations and Helix Innovations. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 42% annual share in 2022. Altria holds a 42% stake in cannabis manufacturer Cronos, has acquired Njoy Holdings in 2023, and recently exited its strategic investment in Juul Labs.
Executives
Clarke Ian L.t. director 6601 W BROAD ST, RICHMOND VA 23230
Robert Matthew Davis director 6601 W. BROAD STREET, RICHMOND VA 23230
Jacinto J Hernandez director 777 HIDDEN RIDGE, IRVING TX 75038
Mario Max Yzaguirre director 1515 WEST 190TH STREET, SUITE 275, GARDENA CA 90248
Marjorie Mary Connelly director 2580 PALMER DR, KESWICK VA 22947
Ellen R Strahlman director ALTRIA GROUP, INC., 6601 W. BROAD STREET, RICHMOND VA 23230
Nabil Y Sakkab director 6601 WEST BROAD STREET, RICHMOND VA 23230
Virginia E Shanks director 4170 CAUGHLIN PARKWAY, RENO NV 89519
Casteen John T Iii director 301 S. COLLEGE STREET, 30TH FLOOR, NC0630, CHARLOTTE NC 28288-0630
Kathryn B. Mcquade director 6601 WEST BROAD STREET, RICHMOND VA 23230
Kiely W Leo Iii director
Mark Newman director 1011 WARRENVILLE ROAD, SUITE 600, LISLE IL 60532
Kelly Ennis Debra J director 4405 A INTERNATIONAL BLVD, NORCROSS GA 30093
Surgner W Hildebrandt Jr officer: VP, Corp. Sec'y & Assoc. GC 6601 WEST BROAD STREET, RICHMOND VA 23230
Daniel J Bryant officer: Vice President & Treasurer 6601 WEST BROAD STREET, RICHMOND VA 23230

Altria Group (Altria Group) Headlines